Home › Sickle Cell Disease
Pag-aaral pangklinika para sa Sickle Cell Disease na nagre-recruit sa U.S.
107 pag-aaral para sa Sickle Cell Disease ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Atlanta, GA22 pag-aaral
- Washington, DC20 pag-aaral
- Chicago, IL18 pag-aaral
- Memphis, TN18 pag-aaral
- Philadelphia, PA15 pag-aaral
- Birmingham, AL14 pag-aaral
- New York City, NY13 pag-aaral
- St. Louis, MO12 pag-aaral
- Boston, MA10 pag-aaral
- Durham, NC10 pag-aaral
- Houston, TX10 pag-aaral
- Cincinnati, OH10 pag-aaral
- Columbus, OH9 pag-aaral
- Greenville, NC9 pag-aaral
- Pittsburgh, PA9 pag-aaral
- The Bronx, NY8 pag-aaral
- Oakland, CA7 pag-aaral
- Baltimore, MD7 pag-aaral
- Charlotte, NC7 pag-aaral
- Cleveland, OH7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Nashville, TN6 pag-aaral
- Richmond, VA6 pag-aaral
- Hartford, CT5 pag-aaral
- Jackson, MS5 pag-aaral
- Detroit, MI5 pag-aaral
- Indianapolis, IN5 pag-aaral
- Phoenix, AZ5 pag-aaral
- Augusta, GA5 pag-aaral
- New Haven, CT4 pag-aaral
- Greenville, SC4 pag-aaral
- Arlington, VA4 pag-aaral
- New Orleans, LA4 pag-aaral
- Milwaukee, WI4 pag-aaral
- Mobile, AL3 pag-aaral
- Edison, NJ3 pag-aaral
- Queens, NY3 pag-aaral
- Minneapolis, MN3 pag-aaral
- Hollywood, FL3 pag-aaral
- Newark, NJ3 pag-aaral
Ayos sa estado
- Alabama16 pag-aaral
- Arizona5 pag-aaral
- Arkansas3 pag-aaral
- California18 pag-aaral
- Connecticut7 pag-aaral
- Delaware6 pag-aaral
- District of Columbia10 pag-aaral
- Florida9 pag-aaral
- Georgia25 pag-aaral
- Illinois19 pag-aaral
- Indiana5 pag-aaral
- Louisiana5 pag-aaral
- Maryland17 pag-aaral
- Massachusetts10 pag-aaral
- Michigan9 pag-aaral
- Minnesota5 pag-aaral
- Mississippi5 pag-aaral
- Missouri13 pag-aaral
- New Jersey8 pag-aaral
- New York21 pag-aaral
- North Carolina18 pag-aaral
- Ohio22 pag-aaral
- Pennsylvania20 pag-aaral
- South Carolina6 pag-aaral
- Tennessee22 pag-aaral
- Texas11 pag-aaral
- Virginia9 pag-aaral
- Wisconsin4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Blood Sampling for Research Related to Sickle Cell Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT00542230Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT03937817A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07656415A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Nagre-recruitPhase 3
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06439082Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06313398A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07187973A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Nagre-recruitPhase 3
Edad 2 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06609226Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05170412A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06612268Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT05904093Tocilizumab for Acute Chest Syndrome
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05640271Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 12 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT02824471Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 2 hanggang 99 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06944067Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing
Nagre-recruit
Edad 8 hanggang 18 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07562451Early Screening and Treatment of Heart Complication in Sickle Cell Disease
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07023666A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 12 hanggang 55 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06546670Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Nagre-recruitPhase 1
Edad 8 hanggang 17 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07226219SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06442761Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Nagre-recruitPhase 1/2
Edad 4 hanggang 65 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07599176Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Nagre-recruitPhase 2
Edad 5 hanggang 20 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07369024Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Nagre-recruitPhase 1
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07566494Cerebrovascular Reactivity Measurements With High-Density Diffuse Optical Tomography
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 6 hanggang 70 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07776444A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Nagre-recruitPhase 2/3
Edad 12 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT05431088A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04398628Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.